Your browser doesn't support javascript.
loading
Risk of Second Primary Thyroid Cancer in Women with Breast Cancer.
Cieszynska, Monika; Kluzniak, Wojciech; Wokolorczyk, Dominika; Cybulski, Cezary; Huzarski, Tomasz; Gronwald, Jacek; Falco, Michal; Debniak, Tadeusz; Jakubowska, Anna; Derkacz, Róza; Marciniak, Wojciech; Lener, Marcin; Woronko, Karolina; Mocarz, Dominika; Baszuk, Piotr; Bryskiewicz, Marta; Narod, Steven A; Lubinski, Jan.
Afiliación
  • Cieszynska M; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, 71-252 Szczecin, Poland.
  • Kluzniak W; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, 71-252 Szczecin, Poland.
  • Wokolorczyk D; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, 71-252 Szczecin, Poland.
  • Cybulski C; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, 71-252 Szczecin, Poland.
  • Huzarski T; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, 71-252 Szczecin, Poland.
  • Gronwald J; Department of Clinical Genetics and Pathology, University of Zielona Góra, 65-417 Zielona Góra, Poland.
  • Falco M; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, 71-252 Szczecin, Poland.
  • Debniak T; West Pomeranian Oncology Center, Radiation Oncology Department, 71-730 Szczecin, Poland.
  • Jakubowska A; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, 71-252 Szczecin, Poland.
  • Derkacz R; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, 71-252 Szczecin, Poland.
  • Marciniak W; Independent Laboratory of Molecular Biology and Genetic Diagnostics, Pomeranian Medical University in Szczecin, 71-252 Szczecin, Poland.
  • Lener M; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, 71-252 Szczecin, Poland.
  • Woronko K; Read-Gene S.A., 72-003 Grzepnica, Poland.
  • Mocarz D; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, 71-252 Szczecin, Poland.
  • Baszuk P; Read-Gene S.A., 72-003 Grzepnica, Poland.
  • Bryskiewicz M; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, 71-252 Szczecin, Poland.
  • Narod SA; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, 71-252 Szczecin, Poland.
  • Lubinski J; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, 71-252 Szczecin, Poland.
Cancers (Basel) ; 14(4)2022 Feb 15.
Article en En | MEDLINE | ID: mdl-35205705
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Polonia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Polonia